SEC Form 4 · accession 0001070081-18-000018
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 3, 2018 | A | 874 | $0.00 | A | 5,284 | I | By spouse |
| Common Stock | Jan 4, 2018 | S | 77 | $17.67 | D | 5,207 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $18.01 | Jan 3, 2018 | A | 70,000 | A | — | Jan 2, 2028 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer.
- F2Includes 1,060 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017.
- F3Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 shares.
- F4This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.